Home
Conditions
Demyelinating Diseases

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,936 public trials 460 recruiting studies

Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis

NCT04823000

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

Mesenchymal Stem Cells for the Treatment of MS

NCT00781872

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

Emotion Regulation Skills Training for Individuals With MS and Their Support Partners

NCT03934489

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Biomarkers and Disease Activity in Patients Treated With Teriflunomide (Aubagio)

NCT03561402

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +7 more
Locations: Department of Pathology Montreal, Quebec, Canada

View Trial Details

Completed

Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS

NCT04145284

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Research Site Cleveland, Ohio, United States

Research Site Dresden, Saxony, Germany

View Trial Details

Completed

Mindfulness for Newly Diagnosed Multiple Sclerosis

NCT03607773

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: London Health Sciences Center London, Ontario, Canada

View Trial Details

Completed

Oral Cladribine in Early Multiple Sclerosis (MS)

NCT00725985

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Hope Research Institute Medical Plaza LLC Desert Hills Phoenix, Arizona, United States

Multiple Sclerosis Center Drive, Neurology Suite 701 Newport Beach, California, United States

University of Colorado at Denver Health Sciences Denver, Colorado, United States

Fort Collins Neurology Fort Collins, Colorado, United States

View all 158 locations

View Trial Details

Completed

Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)

NCT00937157

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +7 more
Locations: Jacobs Neurological Institute Buffalo, New York, United States

View Trial Details

Completed

Cognitive Behavioural Therapy Software for the Treatment of Depression in People With Multiple Sclerosis

NCT00678496

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +7 more
Locations: Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom

View Trial Details

Completed

Behavior Cognitive Therapy on Fatigue Impact in MS Patients

NCT03758820

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cognitive Therapy, +10 more
Locations: Poissy St Germain Hospital Poissy, France

View Trial Details

Demyelinating Diseases

Demyelinating Diseases trial results

Related conditions